1167 related articles for article (PubMed ID: 26295227)
21. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
Elife; 2021 Oct; 10():. PubMed ID: 34713805
[TBL] [Abstract][Full Text] [Related]
22. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.
Bolhassani A
Biochim Biophys Acta; 2011 Dec; 1816(2):232-46. PubMed ID: 21840374
[TBL] [Abstract][Full Text] [Related]
23. Intracellular delivery of nanoparticles with CPPs.
Sawant R; Torchilin V
Methods Mol Biol; 2011; 683():431-51. PubMed ID: 21053148
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
Fonseca SB; Pereira MP; Kelley SO
Adv Drug Deliv Rev; 2009 Sep; 61(11):953-64. PubMed ID: 19538995
[TBL] [Abstract][Full Text] [Related]
25. Peptide-based vectors: recent developments.
Cerrato CP; Lehto T; Langel Ü
Biomol Concepts; 2014 Dec; 5(6):479-88. PubMed ID: 25429600
[TBL] [Abstract][Full Text] [Related]
26. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
27. Versatility of cell-penetrating peptides for intracellular delivery of siRNA.
Singh T; Murthy ASN; Yang HJ; Im J
Drug Deliv; 2018 Nov; 25(1):1996-2006. PubMed ID: 30799658
[TBL] [Abstract][Full Text] [Related]
28. The Primary Mechanism of Cellular Internalization for a Short Cell- Penetrating Peptide as a Nano-Scale Delivery System.
Liu BR; Huang YW; Korivi M; Lo S-Y; Aronstam RS; Lee H-J
Curr Pharm Biotechnol; 2017; 18(7):569-584. PubMed ID: 28828981
[TBL] [Abstract][Full Text] [Related]
29. Intracellular fate of peptide-mediated delivered cargoes.
Martín I; Teixidó M; Giralt E
Curr Pharm Des; 2013; 19(16):2924-42. PubMed ID: 23140455
[TBL] [Abstract][Full Text] [Related]
30. siRNA delivery: from lipids to cell-penetrating peptides and their mimics.
Gooding M; Browne LP; Quinteiro FM; Selwood DL
Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319
[TBL] [Abstract][Full Text] [Related]
31. Combination of Cell-Penetrating Peptides with Nanoparticles for Therapeutic Application: A Review.
Silva S; Almeida AJ; Vale N
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30634689
[TBL] [Abstract][Full Text] [Related]
32. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
Jobin ML; Alves ID
Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
[TBL] [Abstract][Full Text] [Related]
33. Cell-penetrating peptides as nucleic acid delivery systems: from biophysics to biological applications.
Trabulo S; Cardoso AL; Cardoso AM; Morais CM; Jurado AS; Pedroso de Lima MC
Curr Pharm Des; 2013; 19(16):2895-923. PubMed ID: 23140453
[TBL] [Abstract][Full Text] [Related]
34. Cell-penetrating peptides in the intracellular delivery of viral nanoparticles.
Hejtmánková A; Váňová J; Španielová H
Vitam Horm; 2021; 117():47-76. PubMed ID: 34420585
[TBL] [Abstract][Full Text] [Related]
35. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
Kanwar JR; Gibbons J; Verma AK; Kanwar RK
Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
[TBL] [Abstract][Full Text] [Related]
36. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
[TBL] [Abstract][Full Text] [Related]
37. Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides.
Min S; Kim K; Ku S; Park JY; Seo J; Roh S
Biotechnol Prog; 2020 Sep; 36(5):e3014. PubMed ID: 32374475
[TBL] [Abstract][Full Text] [Related]
38. Delivery of nucleic acids, proteins, and nanoparticles by arginine-rich cell-penetrating peptides in rotifers.
Liu BR; Liou JS; Chen YJ; Huang YW; Lee HJ
Mar Biotechnol (NY); 2013 Oct; 15(5):584-95. PubMed ID: 23715807
[TBL] [Abstract][Full Text] [Related]
39. A convergent uptake route for peptide- and polymer-based nucleotide delivery systems.
Lindberg S; Regberg J; Eriksson J; Helmfors H; Muñoz-Alarcón A; Srimanee A; Figueroa RA; Hallberg E; Ezzat K; Langel Ü
J Control Release; 2015 May; 206():58-66. PubMed ID: 25769688
[TBL] [Abstract][Full Text] [Related]
40. Peptides for nucleic acid delivery.
Lehto T; Ezzat K; Wood MJA; El Andaloussi S
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
